Not Medicare Enrolled

Dr. Daniel Gossett, MD

Epilepsy Physician · Dallas, TX
7920 BELT LINE RD STE 685, Dallas, TX 75254
2145446474
Registered in NPPES since 2010
NPI: 1588980072 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gossett from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gossett? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gossett

Dr. Daniel Gossett is an epilepsy physician in Dallas, TX, with 16 years of NPI registration.

Between the years covered by Open Payments, Dr. Gossett received a total of $35,605 from 73 pharmaceutical and/or device companies across 797 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gossett is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years of NPI registration $35,605 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$35,605
Total received (2018-2024)
Avg $5,086/year across 7 years
Top 3% in TX for epilepsy physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
797
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14,852
2023
$10,006
2022
$2,349
2021
$3,011
2020
$1,297
2019
$1,830
2018
$2,259

Payments by company (2024)

Marinus Pharmaceuticals, Inc.
$12,361
UCB, Inc.
$325
ACADIA Pharmaceuticals Inc
$239
Eisai Inc.
$231
Merz Pharmaceuticals, LLC
$202
ARGENX US, INC.
$171
Ipsen Biopharmaceuticals, Inc
$106
Neurelis, Inc.
$103
TG Therapeutics, Inc.
$97
Teva Pharmaceuticals USA, Inc.
$93
SK Life Science, Inc.
$89
ABBVIE INC.
$88
Alexion Pharmaceuticals, Inc.
$86
LivaNova USA, Inc.
$83
JAZZ PHARMACEUTICALS INC.
$78
Biogen, Inc.
$67
Neurocrine Biosciences, Inc.
$49
Octapharma USA, Inc.
$46
Grifols USA, LLC
$44
ANI Pharmaceuticals, Inc.
$41
Kedrion Biopharma, Inc.
$40
Aucta Pharmaceuticals, Inc.
$29
Supernus Pharmaceuticals, Inc.
$25
Amneal Pharmaceuticals LLC
$24
REVANCE THERAPEUTICS, INC.
$24
Lilly USA, LLC
$21
CATALYST PHARMACEUTICALS, INC.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
Lundbeck LLC
$17
GE HEALTHCARE
$14
Sumitomo Pharma America, Inc.
$13
Cycle Pharmaceuticals Inc
$9
Top 3 companies account for 87.0% of 2024 payments
All-time payments by company (2018-2024) ›
Marinus Pharmaceuticals, Inc.
$15,902
BioMarin Pharmaceutical Inc.
$5,118
UCB, Inc.
$1,199
Ironshore Pharmaceuticals Inc.
$1,092
Supernus Pharmaceuticals, Inc.
$1,085
NATUS MEDICAL INCORPORATED
$1,012
Sunovion Pharmaceuticals Inc.
$860
LivaNova USA, Inc.
$693
Eisai Inc.
$666
Tris Pharma Inc
$665
Neos Therapeutics, LP
$646
Neurelis, Inc.
$616
SK Life Science, Inc.
$447
JAZZ PHARMACEUTICALS INC.
$442
EISAI INC.
$372
Corium, LLC
$343
AQUESTIVE THERAPEUTICS, INC.
$294
ACADIA Pharmaceuticals Inc
$239
Shire North American Group Inc
$227
Takeda Pharmaceuticals U.S.A., Inc.
$214
Adlon Therapeutics L.P.
$212
Merz Pharmaceuticals, LLC
$202
Lundbeck LLC
$190
Sumitomo Pharma America, Inc.
$187
Zogenix Inc.
$180
ARGENX US, INC.
$171
Biohaven Pharmaceuticals, Inc.
$166
Aprecia Pharmaceuticals, LLC
$160
Ipsen Biopharmaceuticals, Inc
$129
Biogen, Inc.
$126
ABBVIE INC.
$114
ARBOR PHARMACEUTICALS, INC.
$113
Alexion Pharmaceuticals, Inc.
$103
TG Therapeutics, Inc.
$97
Teva Pharmaceuticals USA, Inc.
$93
GENZYME CORPORATION
$68
Validus Pharmaceuticals LLC
$65
Amneal Pharmaceuticals LLC
$60
Allergan, Inc.
$53
Avion Pharmaceuticals
$50
Neurocrine Biosciences, Inc.
$49
NS Pharma, Inc.
$47
Octapharma USA, Inc.
$46
Grifols USA, LLC
$44
PTC Therapeutics, Inc.
$43
PFIZER INC.
$42
Cranial Technologies, Inc
$41
ANI Pharmaceuticals, Inc.
$41
Kedrion Biopharma, Inc.
$40
Travere Therapeutics, Inc.
$36
NEUROPACE, INC.
$33
Biohaven Pharmaceutical Holding Company Ltd.
$32
Sarepta Therapeutics, Inc.
$32
Mallinckrodt Enterprises LLC
$32
Lupin Inc.
$30
Biocodex, Inc.
$30
Aucta Pharmaceuticals, Inc.
$29
Azurity Pharmaceuticals, Inc.
$26
Corium, Inc.
$25
Arbor Pharmaceuticals, Inc.
$24
REVANCE THERAPEUTICS, INC.
$24
Lilly USA, LLC
$21
Noven Therapeutics, LLC
$20
CATALYST PHARMACEUTICALS, INC.
$18
Mallinckrodt LLC
$18
Upsher-Smith Laboratories LLC
$17
Vertical Pharmaceuticals, LLC
$17
Catalyst Pharmaceuticals, Inc.
$15
Mallinckrodt Hospital Products Inc.
$15
HARMONY BIOSCIENCES LLC
$15
GE HEALTHCARE
$14
Retrophin, Inc.
$10
Cycle Pharmaceuticals Inc
$9
Top 3 companies account for 62.4% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ADHANSIA XR · AMYVID · APTIOM · AZSTARYS · Adzenys XR-ODT · Albuked · Austedo XR · Azstarys · BOTOX · BRIUMVI · Brineura · Briviact · COTEMPLA XR-ODT · Cholbam · Cotempla XR-ODT · DAXXIFY · DAYBUE · DIACOMIT · Doc Band · Dyanavel XR · Dysport · EMFLAZA · EPIDIOLEX · Eprontia · Equetro · Evekeo · Evekeo ODT · Exondys 51 · FYCOMPA · Fintepla · Fycompa · Gamunex-C · HYQVIA · Horizant · INGREZZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LUMIZYME · Leqembi · METHYLPHENIDATE 72 · MYDAYIS · Methylphenidate Hydrochloride · Motpoly XR · NUPLAZID · NURTEC ODT · Nayzilam · ONFI · OXTELLAR XR · PANZYGA · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · QELBREE · QUILLIVANT XR · Qelbree · Quillichew ER · Quillivant · Quillivant XR · RNS System · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SUPRAX · SYMPAZAN · Spritam · TROKENDI XR · Tascenso ODT · ULTOMIRIS · VALTOCO · VIGADRONE (VIGABATRIN) FOR ORAL SOLUTION · VILTEPSO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VYEPTI · VYVANSE · VYVGART HYTRULO · VascuClear · Vimizim · Vimpat · Wakix · XCOPRI · XYREM · Xelstrym · Xeomin · ZOMIG · ZTALMY
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an epilepsy physician in Dallas?
Compare epilepsy physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse epilepsy physicians nearby

Geographic Context

Epilepsy physicians in nearby ZIP areas
8
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY GREEN OAKS HOSPITAL
2.2 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gossett is an epilepsy physician, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Gossett receive payments from pharmaceutical companies?
Yes. Dr. Gossett received a total of $35,605 from 73 companies across 797 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Gossett) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Epilepsy Physicians in Dallas
Browse epilepsy physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Epilepsy Physicians in TX
Epilepsy physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Epilepsy Physicians in TX
Which TX epilepsy physicians receive the most from drug and device companies.
By company
Marinus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Marinus Pharmaceuticals, Inc.
By company
BioMarin Pharmaceutical Inc. Payments to Doctors
See all physicians who received payments from BioMarin Pharmaceutical Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →